Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 270

1.

Cannabis Use in Children With Pantothenate Kinase-Associated Neurodegeneration.

Wilson JL, Gregory A, Wakeman K, Freed A, Rai P, Roberts C, Hayflick SJ, Hogarth P.

J Child Neurol. 2019 Dec 11:883073819890516. doi: 10.1177/0883073819890516. [Epub ahead of print]

PMID:
31823681
2.

TB testing and levels of bovine TB in England.

Middlemiss C, de la Rua-Domenech R, Downs S, Smith G, Brown E, McCormack J, Wade C, Hogarth P, Gerrard Z.

Vet Rec. 2019 Nov 30;185(21):664. doi: 10.1136/vr.l6696. No abstract available.

PMID:
31780509
3.

Distinguishing human peripheral blood CD16+ myeloid cells based on phenotypic characteristics.

Fromm PD, Silveira PA, Hsu JL, Papadimitrious MS, Lo TH, Ju X, Kupresanin F, Romano A, Hsu WH, Bryant CE, Kong B, Abadir E, Mekkawy A, M McGuire H, Groth BFS, Cunningham I, Newman E, Gibson J, Hogarth PM, Hart DNJ, Clark GJ.

J Leukoc Biol. 2019 Nov 21. doi: 10.1002/JLB.5A1119-362RRR. [Epub ahead of print]

PMID:
31749181
4.

Low pH Exposure During Immunoglobulin G Purification Methods Results in Aggregates That Avidly Bind Fcγ Receptors: Implications for Measuring Fc Dependent Antibody Functions.

Lopez E, Scott NE, Wines BD, Hogarth PM, Wheatley AK, Kent SJ, Chung AW.

Front Immunol. 2019 Oct 11;10:2415. doi: 10.3389/fimmu.2019.02415. eCollection 2019.

5.

4'-Phosphopantetheine corrects CoA, iron, and dopamine metabolic defects in mammalian models of PKAN.

Jeong SY, Hogarth P, Placzek A, Gregory AM, Fox R, Zhen D, Hamada J, van der Zwaag M, Lambrechts R, Jin H, Nilsen A, Cobb J, Pham T, Gray N, Ralle M, Duffy M, Schwanemann L, Rai P, Freed A, Wakeman K, Woltjer RL, Sibon OC, Hayflick SJ.

EMBO Mol Med. 2019 Dec;11(12):e10489. doi: 10.15252/emmm.201910489. Epub 2019 Oct 29.

6.

Transportation innovation to aid Parkinson disease trial recruitment.

Frank S, Berk S, Hernandez L, Hogarth P, Shill HA, Siddiqi B, Simon DK.

Contemp Clin Trials Commun. 2019 Sep 10;16:100449. doi: 10.1016/j.conctc.2019.100449. eCollection 2019 Dec.

7.

Plasma levels of the soluble form of the FcγRIIa receptor vary with receptor polymorphisms and are elevated in rheumatoid arthritis.

Qiao J, Dunne E, Wines B, Kenny D, McCarthy GM, Hogarth PM, Xu K, Andrews RK, Gardiner EE.

Platelets. 2019 Aug 4:1-7. doi: 10.1080/09537104.2019.1647527. [Epub ahead of print]

PMID:
31378115
8.

CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiation.

Abadir E, Gasiorowski RE, Lai K, Kupresanin F, Romano A, Silveira PA, Lo TH, Fromm PD, Kennerson ML, Iland HJ, Ho PJ, Hogarth PM, Bradstock K, Hart DNJ, Clark GJ.

Mol Oncol. 2019 Oct;13(10):2107-2120. doi: 10.1002/1878-0261.12549. Epub 2019 Aug 20.

9.

Boosting of Markers of Fcγ Receptor Function in Anti-HIV Antibodies During Structured Treatment Interruption.

Billings H, Wines BD, Dyer WB, Center RJ, Trist HM, Kent SJ, Hogarth PM.

AIDS Res Hum Retroviruses. 2019 Sep;35(9):842-852. doi: 10.1089/AID.2019.0047. Epub 2019 Aug 21.

10.

Motor phenotype classification in moderate to advanced PD in BioFIND study.

Luo L, Andrews H, Alcalay RN, Poyraz FC, Boehme AK, Goldman JG, Xie T, Tuite P, Henchcliffe C, Hogarth P, Amara AW, Frank S, Sutherland M, Kopil C, Naito A, Kang UJ.

Parkinsonism Relat Disord. 2019 Aug;65:178-183. doi: 10.1016/j.parkreldis.2019.06.017. Epub 2019 Jun 23.

PMID:
31255537
11.

Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study.

Klopstock T, Tricta F, Neumayr L, Karin I, Zorzi G, Fradette C, Kmieć T, Büchner B, Steele HE, Horvath R, Chinnery PF, Basu A, Küpper C, Neuhofer C, Kálmán B, Dušek P, Yapici Z, Wilson I, Zhao F, Zibordi F, Nardocci N, Aguilar C, Hayflick SJ, Spino M, Blamire AM, Hogarth P, Vichinsky E.

Lancet Neurol. 2019 Jul;18(7):631-642. doi: 10.1016/S1474-4422(19)30142-5.

PMID:
31202468
12.

Autosomal dominant mitochondrial membrane protein-associated neurodegeneration (MPAN).

Gregory A, Lotia M, Jeong SY, Fox R, Zhen D, Sanford L, Hamada J, Jahic A, Beetz C, Freed A, Kurian MA, Cullup T, van der Weijden MCM, Nguyen V, Setthavongsack N, Garcia D, Krajbich V, Pham T, Woltjer R, George BP, Minks KQ, Paciorkowski AR, Hogarth P, Jankovic J, Hayflick SJ.

Mol Genet Genomic Med. 2019 Jul;7(7):e00736. doi: 10.1002/mgg3.736. Epub 2019 May 13.

13.

MECR-Related Neurologic Disorder.

Heimer G, Gregory A, Hogarth P, Hayflick S, Ben Zeev B.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020.
2019 May 9.

14.

The Human FcγRII (CD32) Family of Leukocyte FcR in Health and Disease.

Anania JC, Chenoweth AM, Wines BD, Hogarth PM.

Front Immunol. 2019 Mar 19;10:464. doi: 10.3389/fimmu.2019.00464. eCollection 2019. Review.

15.

Activated platelets in the tumor microenvironment for targeting of antibody-drug conjugates to tumors and metastases.

Yap ML, McFadyen JD, Wang X, Ziegler M, Chen YC, Willcox A, Nowell CJ, Scott AM, Sloan EK, Hogarth PM, Pietersz GA, Peter K.

Theranostics. 2019 Feb 7;9(4):1154-1169. doi: 10.7150/thno.29146. eCollection 2019.

16.

Novel Impactor and Microsphere-Based Assay Used to Measure Containment of Aerosols Generated in a Flow Cytometer Cell Sorter.

Perfetto SP, Hogarth PJ, Monard S, Fontes B, Reifel KM, Swan BK, Baijer J, Jellison ER, Lyon G, Lovelace P, Nguyen R, Ambrozak D, Holmes KL.

Cytometry A. 2019 Feb;95(2):173-182. doi: 10.1002/cyto.a.23680. Epub 2018 Dec 18.

PMID:
30561906
17.

Fc-dependent functions are redundant to efficacy of anti-HIV antibody PGT121 in macaques.

Parsons MS, Lee WS, Kristensen AB, Amarasena T, Khoury G, Wheatley AK, Reynaldi A, Wines BD, Hogarth PM, Davenport MP, Kent SJ.

J Clin Invest. 2019 Jan 2;129(1):182-191. doi: 10.1172/JCI122466. Epub 2018 Nov 26.

18.

Enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1+ KLRG1- CD4+ T cells.

Bull NC, Stylianou E, Kaveh DA, Pinpathomrat N, Pasricha J, Harrington-Kandt R, Garcia-Pelayo MC, Hogarth PJ, McShane H.

Mucosal Immunol. 2019 Mar;12(2):555-564. doi: 10.1038/s41385-018-0109-1. Epub 2018 Nov 16.

PMID:
30446726
19.

Two Families of Env Antibodies Efficiently Engage Fc-Gamma Receptors and Eliminate HIV-1-Infected Cells.

Anand SP, Prévost J, Baril S, Richard J, Medjahed H, Chapleau JP, Tolbert WD, Kirk S, Smith AB 3rd, Wines BD, Kent SJ, Hogarth PM, Parsons MS, Pazgier M, Finzi A.

J Virol. 2019 Jan 17;93(3). pii: e01823-18. doi: 10.1128/JVI.01823-18. Print 2019 Feb 1.

20.

Assessment of an Objective Method of Dyskinesia Measurement in Parkinson's Disease.

Chung KA, Lobb BM, Murchison CF, Mancini M, Hogarth P, Nutt JG.

Mov Disord Clin Pract. 2018 Mar 2;5(2):160-164. doi: 10.1002/mdc3.12583. eCollection 2018 Mar-Apr.

21.

Dimeric FcγR ectodomains detect pathogenic anti-platelet factor 4-heparin antibodies in heparin-induced thromobocytopenia.

Wines BD, Tan CW, Duncan E, McRae S, Baker RI, Andrews RK, Esparon S, Gardiner EE, Hogarth PM.

J Thromb Haemost. 2018 Dec;16(12):2520-2525. doi: 10.1111/jth.14306. Epub 2018 Nov 20.

22.

The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1.

Anania JC, Trist HM, Palmer CS, Tan PS, Kouskousis BP, Chenoweth AM, Kent SJ, Mackay GA, Hoi A, Koelmeyer R, Slade C, Bryant VL, Hodgkin PD, Aui PM, van Zelm MC, Wines BD, Hogarth PM.

Front Immunol. 2018 Aug 20;9:1809. doi: 10.3389/fimmu.2018.01809. eCollection 2018.

23.

Induction and maintenance of a phenotypically heterogeneous lung tissue-resident CD4+ T cell population following BCG immunisation.

Bull NC, Kaveh DA, Garcia-Pelayo MC, Stylianou E, McShane H, Hogarth PJ.

Vaccine. 2018 Sep 5;36(37):5625-5635. doi: 10.1016/j.vaccine.2018.07.035. Epub 2018 Aug 7.

24.

Anti-Influenza Hyperimmune Immunoglobulin Enhances Fc-Functional Antibody Immunity During Human Influenza Infection.

Vanderven HA, Wragg K, Ana-Sosa-Batiz F, Kristensen AB, Jegaskanda S, Wheatley AK, Wentworth D, Wines BD, Hogarth PM, Rockman S, Kent SJ; INSIGHT FLU005 Pilot Study Writing Group.

J Infect Dis. 2018 Sep 22;218(9):1383-1393. doi: 10.1093/infdis/jiy328.

25.

The cell surface phenotype of human dendritic cells.

Clark GJ, Silveira PA, Hogarth PM, Hart DNJ.

Semin Cell Dev Biol. 2019 Feb;86:3-14. doi: 10.1016/j.semcdb.2018.02.013. Epub 2018 Mar 27. Review.

PMID:
29499385
26.

Looking Deep into the Eye-of-the-Tiger in Pantothenate Kinase-Associated Neurodegeneration.

Lee JH, Gregory A, Hogarth P, Rogers C, Hayflick SJ.

AJNR Am J Neuroradiol. 2018 Mar;39(3):583-588. doi: 10.3174/ajnr.A5514. Epub 2018 Jan 25.

27.

Neurodegeneration with brain iron accumulation.

Hayflick SJ, Kurian MA, Hogarth P.

Handb Clin Neurol. 2018;147:293-305. doi: 10.1016/B978-0-444-63233-3.00019-1. Review.

PMID:
29325618
28.

Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features.

Goldman JG, Andrews H, Amara A, Naito A, Alcalay RN, Shaw LM, Taylor P, Xie T, Tuite P, Henchcliffe C, Hogarth P, Frank S, Saint-Hilaire MH, Frasier M, Arnedo V, Reimer AN, Sutherland M, Swanson-Fischer C, Gwinn K; Fox Investigation of New Biomarker Discovery, Kang UJ.

Mov Disord. 2018 Feb;33(2):282-288. doi: 10.1002/mds.27232. Epub 2017 Dec 4.

29.

Antibody-Dependent Cellular Cytotoxicity Responses to Seasonal Influenza Vaccination in Older Adults.

Vanderven HA, Jegaskanda S, Wines BD, Hogarth PM, Carmuglia S, Rockman S, Chung AW, Kent SJ.

J Infect Dis. 2017 Dec 27;217(1):12-23. doi: 10.1093/infdis/jix554.

PMID:
29106590
30.

Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adults.

Ana-Sosa-Batiz F, Johnston APR, Hogarth PM, Wines BD, Barr I, Wheatley AK, Kent SJ.

Vaccine. 2017 Nov 7;35(47):6451-6458. doi: 10.1016/j.vaccine.2017.09.062. Epub 2017 Oct 10.

PMID:
29029940
31.

Targeting Activated Platelets: A Unique and Potentially Universal Approach for Cancer Imaging.

Yap ML, McFadyen JD, Wang X, Zia NA, Hohmann JD, Ziegler M, Yao Y, Pham A, Harris M, Donnelly PS, Hogarth PM, Pietersz GA, Lim B, Peter K.

Theranostics. 2017 Jun 25;7(10):2565-2574. doi: 10.7150/thno.19900. eCollection 2017.

32.

Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection.

Parsons MS, Lloyd SB, Lee WS, Kristensen AB, Amarasena T, Center RJ, Keele BF, Lifson JD, LaBranche CC, Montefiori D, Wines BD, Hogarth PM, Swiderek KM, Venturi V, Davenport MP, Kent SJ.

Sci Transl Med. 2017 Aug 9;9(402). pii: eaaf1483. doi: 10.1126/scitranslmed.aaf1483.

PMID:
28794282
33.

Portable objective assessment of upper extremity motor function in Parkinson's disease.

Chahine LM, Uribe L, Hogarth P, McNames J, Siderowf A, Marek K, Jennings D.

Parkinsonism Relat Disord. 2017 Oct;43:61-66. doi: 10.1016/j.parkreldis.2017.07.017. Epub 2017 Jul 19.

PMID:
28747279
34.

HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV.

Madhavi V, Wines BD, Amin J, Emery S; ENCORE1 Study Group, Lopez E, Kelleher A; Sydney LTNP Study Group, Center RJ, Hogarth PM, Chung AW, Kent SJ, Stratov I.

J Virol. 2017 Aug 24;91(18). pii: e00700-17. doi: 10.1128/JVI.00700-17. Print 2017 Sep 15.

35.

Fc functional antibodies in humans with severe H7N9 and seasonal influenza.

Vanderven HA, Liu L, Ana-Sosa-Batiz F, Nguyen TH, Wan Y, Wines B, Hogarth PM, Tilmanis D, Reynaldi A, Parsons MS, Hurt AC, Davenport MP, Kotsimbos T, Cheng AC, Kedzierska K, Zhang X, Xu J, Kent SJ.

JCI Insight. 2017 Jul 6;2(13). pii: 92750. doi: 10.1172/jci.insight.92750. eCollection 2017 Jul 6.

36.

Dimeric Fcγ Receptor Enzyme-Linked Immunosorbent Assay To Study HIV-Specific Antibodies: A New Look into Breadth of Fcγ Receptor Antibodies Induced by the RV144 Vaccine Trial.

McLean MR, Madhavi V, Wines BD, Hogarth PM, Chung AW, Kent SJ.

J Immunol. 2017 Jul 15;199(2):816-826. doi: 10.4049/jimmunol.1602161. Epub 2017 Jun 14.

37.

A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens.

Kratochvil S, McKay PF, Kopycinski JT, Bishop C, Hayes PJ, Muir L, Pinder CL, Cizmeci D, King D, Aldon Y, Wines BD, Hogarth PM, Chung AW, Kent SJ, Held K, Geldmacher C, Dally L, Santos NS, Cole T, Gilmour J, Fidler S, Shattock RJ.

Front Immunol. 2017 May 24;8:595. doi: 10.3389/fimmu.2017.00595. eCollection 2017.

38.

Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment Interruption.

Lee WS, Kristensen AB, Rasmussen TA, Tolstrup M, Østergaard L, Søgaard OS, Wines BD, Hogarth PM, Reynaldi A, Davenport MP, Emery S, Amin J, Cooper DA, Kan VL, Fox J, Gruell H, Parsons MS, Kent SJ.

J Virol. 2017 Jul 12;91(15). pii: e00603-17. doi: 10.1128/JVI.00603-17. Print 2017 Aug 1.

39.

Changes in Red Blood Cell membrane lipid composition: A new perspective into the pathogenesis of PKAN.

Aoun M, Corsetto PA, Nugue G, Montorfano G, Ciusani E, Crouzier D, Hogarth P, Gregory A, Hayflick S, Zorzi G, Rizzo AM, Tiranti V.

Mol Genet Metab. 2017 Jun;121(2):180-189. doi: 10.1016/j.ymgme.2017.04.006. Epub 2017 Apr 18.

PMID:
28456385
40.

Novel Solutions for Vaccines and Diagnostics To Combat Brucellosis.

Mandal SS, Duncombe L, Ganesh NV, Sarkar S, Howells L, Hogarth PJ, Bundle DR, McGiven J.

ACS Cent Sci. 2017 Mar 22;3(3):224-231. doi: 10.1021/acscentsci.7b00019. Epub 2017 Mar 3.

41.

Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts.

Madhavi V, Kulkarni A, Shete A, Lee WS, Mclean MR, Kristensen AB, Ghate M, Wines BD, Hogarth PM, Parsons MS, Kelleher A, Cooper DA, Amin J, Emery S, Thakar M, Kent SJ; ENCORE1 Study Group.

J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):345-353. doi: 10.1097/QAI.0000000000001380.

PMID:
28346319
42.

Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field.

Wines BD, Billings H, Mclean MR, Kent SJ, Hogarth PM.

Curr HIV Res. 2017;15(3):202-215. doi: 10.2174/1570162X15666170320112247. Review.

43.

PLA2G6-Associated Neurodegeneration.

Gregory A, Kurian MA, Maher ER, Hogarth P, Hayflick SJ.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020.
2008 Jun 19 [updated 2017 Mar 23].

44.

Beta-Propeller Protein-Associated Neurodegeneration.

Gregory A, Kurian MA, Haack T, Hayflick SJ, Hogarth P.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020.
2017 Feb 16.

45.

CD1- and CD1+ porcine blood dendritic cells are enriched for the orthologues of the two major mammalian conventional subsets.

Edwards JC, Everett HE, Pedrera M, Mokhtar H, Marchi E, Soldevila F, Kaveh DA, Hogarth PJ, Johns HL, Nunez-Garcia J, Steinbach F, Crooke HR, Graham SP.

Sci Rep. 2017 Jan 20;7:40942. doi: 10.1038/srep40942.

46.

Consensus clinical management guideline for pantothenate kinase-associated neurodegeneration (PKAN).

Hogarth P, Kurian MA, Gregory A, Csányi B, Zagustin T, Kmiec T, Wood P, Klucken A, Scalise N, Sofia F, Klopstock T, Zorzi G, Nardocci N, Hayflick SJ.

Mol Genet Metab. 2017 Mar;120(3):278-287. doi: 10.1016/j.ymgme.2016.11.004. Epub 2016 Dec 27. No abstract available.

PMID:
28034613
47.

MECR Mutations Cause Childhood-Onset Dystonia and Optic Atrophy, a Mitochondrial Fatty Acid Synthesis Disorder.

Heimer G, Kerätär JM, Riley LG, Balasubramaniam S, Eyal E, Pietikäinen LP, Hiltunen JK, Marek-Yagel D, Hamada J, Gregory A, Rogers C, Hogarth P, Nance MA, Shalva N, Veber A, Tzadok M, Nissenkorn A, Tonduti D, Renaldo F; University of Washington Center for Mendelian Genomics, Kraoua I, Panteghini C, Valletta L, Garavaglia B, Cowley MJ, Gayevskiy V, Roscioli T, Silberstein JM, Hoffmann C, Raas-Rothschild A, Tiranti V, Anikster Y, Christodoulou J, Kastaniotis AJ, Ben-Zeev B, Hayflick SJ.

Am J Hum Genet. 2016 Dec 1;99(6):1229-1244. doi: 10.1016/j.ajhg.2016.09.021. Epub 2016 Nov 3.

48.

Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy.

Dyer WB, Tan JC, Day T, Kiers L, Kiernan MC, Yiannikas C, Reddel S, Ng K, Mondy P, Dennington PM, Dean MM, Trist HM, Dos Remedios C, Hogarth PM, Vucic S, Irving DO.

Brain Behav. 2016 Jul 14;6(10):e00516. eCollection 2016 Oct.

49.

Distinctive expression of interleukin-23 receptor subunits on human Th17 and γδ T cells.

Wines BD, Yap ML, Powell MS, Tan PS, Ko KK, Orlowski E, Hogarth PM.

Immunol Cell Biol. 2017 Mar;95(3):272-279. doi: 10.1038/icb.2016.93. Epub 2016 Sep 20.

PMID:
27645493
50.

Targeting B cells in treatment of autoimmunity.

Franks SE, Getahun A, Hogarth PM, Cambier JC.

Curr Opin Immunol. 2016 Dec;43:39-45. doi: 10.1016/j.coi.2016.09.003. Epub 2016 Oct 5. Review.

Supplemental Content

Loading ...
Support Center